Insider Trading & Ownership of Fred E. Cohen

Location: Fort Worth, TX
Summary: The estimated net worth of Fred E. Cohen is at least $15,056,328 dollars as of 07 Jan 2026. Fred E. Cohen is the Director, 10%+ Owner of Kyverna Therapeutics, Inc. and owns shares of Kyverna Therapeutics, Inc. (KYTX) stock worth about $9.58M. Fred E. Cohen is the Director of CareDx, Inc. and owns shares of CareDx, Inc. (CDNA) stock worth about $2.81M. Fred E. Cohen is the Director of Intellia Therapeutics, Inc. and owns shares of Intellia Therapeutics, Inc. (NTLA) stock worth about $1.94M. Fred E. Cohen is the Director of Progyny, Inc. and owns shares of Progyny, Inc. (PGNY) stock worth about $725K.
Signature: /s/ James Basta, attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when Fred E. Cohen files a new Insider Trading report.

Ownership of Fred E. Cohen

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
KYTX	Kyverna Therapeutics, Inc.	Director, 10%+ Owner	$9,580,576			29 May 2025
CDNA	CareDx, Inc.	Director	$2,811,026			13 Jun 2025
NTLA	Intellia Therapeutics, Inc.	Director	$1,939,685	+$1,402,500	+261%	05 Jan 2026
PGNY	Progyny, Inc.	Director	$725,041			23 May 2024
URGN	UroGen Pharma Ltd.	Director				06 Aug 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.